8 Knots Management LLC Purchases 623,602 Shares of Enhabit, Inc. (NYSE:EHAB)

8 Knots Management LLC boosted its position in shares of Enhabit, Inc. (NYSE:EHAB) by 16.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,430,898 shares of the company’s stock after purchasing an additional 623,602 shares during the period. Enhabit makes up 3.5% of 8 Knots Management LLC’s portfolio, making the stock its 10th biggest position. 8 Knots Management LLC owned 0.09% of Enhabit worth $34,605,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in EHAB. Quantbot Technologies LP purchased a new position in shares of Enhabit during the 4th quarter valued at approximately $45,000. Corient Private Wealth LLC acquired a new stake in Enhabit in the fourth quarter valued at $79,000. Quarry LP boosted its stake in Enhabit by 692.6% during the 4th quarter. Quarry LP now owns 10,811 shares of the company’s stock valued at $84,000 after acquiring an additional 9,447 shares during the last quarter. Stoneridge Investment Partners LLC grew its holdings in Enhabit by 22.6% during the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company’s stock worth $98,000 after acquiring an additional 2,308 shares in the last quarter. Finally, Boothbay Fund Management LLC bought a new stake in shares of Enhabit in the 4th quarter worth about $106,000.

Enhabit Stock Performance

Enhabit stock opened at $7.93 on Tuesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $10.70. The company has a fifty day moving average price of $8.30 and a two-hundred day moving average price of $8.01. The company has a market cap of $400.31 million, a PE ratio of -3.42 and a beta of 1.60.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.